Interventional management of gastroduodenal lesions complicating intra-arterial hepatic chemotherapy

[1]  K. Brown,et al.  Arterial embolization for salvage of hepatic artery infusion pumps. , 2006, Journal of vascular and interventional radiology : JVIR.

[2]  Jae Hyung Park,et al.  Nonhepatic arteries originating from the hepatic arteries: angiographic analysis in 250 patients. , 2006, Journal of vascular and interventional radiology : JVIR.

[3]  F. Orsi,et al.  Iatrogenic gastroduodenal ulcers during hepatic intra-arterial chemotherapy. , 2003, Hepato-gastroenterology.

[4]  M. Salvioni,et al.  Percutaneous vs. surgical placement of hepatic artery indwelling catheters for regional chemotherapy. , 2002, Hepato-gastroenterology.

[5]  Y. Inaba,et al.  Right gastric artery embolization to prevent acute gastric mucosal lesions in patients undergoing repeat hepatic arterial infusion chemotherapy. , 2001, Journal of vascular and interventional radiology : JVIR.

[6]  H. Sittek,et al.  Liver intraarterial chemotherapy: use of the femoral artery for percutaneous implantation of catheter-port systems. , 2000, Radiology.

[7]  H. Seki,et al.  Gastric toxicity related to perfusion of the stomach via the left inferior phrenic artery during hepatic arterial infusion chemotherapy: report of two cases. , 1999, Radiation medicine.

[8]  Mark Wilson,et al.  Transcatheter Embolization for the Treatment of Misperfusion After Hepatic Artery Chemoinfusion Pump Implantation , 1999, Annals of Surgical Oncology.

[9]  H. Seki,et al.  Development of extrahepatic arterial blood supply to the liver during hepatic arterial infusion chemotherapy , 1998, European Radiology.

[10]  B. Levin,et al.  Gastric mucosal injury after hepatic arterial infusion chemotherapy with floxuridine. A clinical and pathologic study , 1994, Cancer.

[11]  E. Ring,et al.  Hepatic intra-arterial methylene blue injection during endoscopy: a method of detecting gastroduodenal misperfusion in patients receiving hepatic intra-arterial chemotherapy via an implanted pump. , 1992, Gastrointestinal endoscopy.

[12]  R. Larson,et al.  Gastroduodenal artery‐duodenal fistula: A complication of continuous floxuridine (FUDR) infusion into the gastroduodenal artery , 1990, Journal of Surgical Oncology.

[13]  P D Schneider,et al.  A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. , 1987, Annals of surgery.

[14]  N. Geller,et al.  Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial. , 1987, Annals of internal medicine.

[15]  D. Weaver,et al.  Upper gastrointestinal endoscopy for diagnosis of complications of regional hepatic chemotherapy. , 1986, The American surgeon.

[16]  D. Price,et al.  Avoidance of gastroduodenal toxicity in patients receiving hepatic arterial 5-fluoro-2'-deoxyuridine. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  R. Bukowski,et al.  Gastric epithelial atypia associated with hepatic arterial infusion chemotherapy. Its distinction from early gastric carcinoma , 1985, Cancer.

[18]  P. Jönsson,et al.  Upper G-I bleeding following intraarterial chemotherapy infusion. , 1983, Annales chirurgiae et gynaecologiae.

[19]  S. Wallace,et al.  Hepatic artery infusion chemotherapy: gastroduodenal complications. , 1981, AJR. American journal of roentgenology.

[20]  V. Vaitkevicius,et al.  The practicality of chronic hepatic artery infusion therapy of primary and metastatic hepatic malignancies: Ten‐year results of 124 patients in a prospective protocol , 1981, Cancer.

[21]  W. Wolberg,et al.  Gastric Ulceration in Patients Receiving Intrahepatic Infusion of 5‐Fluorouracil , 1977, Annals of surgery.